Implementing Defense Strategies for New York Federal Offenses.

Federal crimes are prosecuted in the United States District Court for the Southern District of New York (SDNY) or the Eastern District of New York (EDNY) and are governed by federal statutes, not New York Penal Law. State crimes are prosecuted in New York county courts under state law and carry different sentencing guidelines, investigative procedures, and collateral consequences.

Federal jurisdiction typically applies when a criminal act involves federal property, federal employees, interstate commerce, or violations of federal statutes such as the Securities Exchange Act, Internal Revenue Code, or the Controlled Substances Act. From a practitioner's perspective, the distinction matters because federal prosecutors have greater investigative resources, grand jury authority, and sentencing discretion under the U.S. Sentencing Guidelines. Corporations must recognize that a single transaction can trigger both federal and state investigation simultaneously, creating parallel enforcement tracks that require coordinated response strategies.

Federal law enforcement agencies, including the Federal Bureau of Investigation, Internal Revenue Service Criminal Investigation Division, and Drug Enforcement Administration, possess broad subpoena authority and can compel production of corporate records, employee testimony, and electronic communications. Grand jury subpoenas in federal court can reach documents and witnesses that state investigators cannot easily access. Corporations often discover federal investigation only after receiving a subpoena or a target letter from the U.S. Attorney's Office, at which point privilege preservation and document retention become critical. Failure to comply with subpoenas or obstruction of a federal investigation compounds criminal exposure significantly.

Corporations in New York face heightened exposure to federal charges involving tax evasion, healthcare fraud, securities violations, money laundering, and federal drug crime liability for employee or supply-chain conduct.

Tax crimes include filing false returns, structuring deposits to evade reporting requirements, and claiming fraudulent deductions. Healthcare fraud typically involves overbilling Medicare or Medicaid, submitting false claims, or kickback schemes. Securities violations include insider trading, offering unregistered securities, or misrepresenting financial performance. Each category carries mandatory minimum sentences, substantial fines, and restitution obligations. Corporations cannot simply blame individual actors; federal law holds entities criminally liable for employee conduct undertaken within the scope of employment and intended to benefit the corporation, even if senior management did not authorize or know of the specific conduct.

When a corporation is convicted, the U.S. Sentencing Guidelines for Organizations determine the financial penalty range based on the offense level and the organization's culpability score. The Guidelines reward corporations that had effective compliance programs, conducted internal investigations, and self-reported violations; they penalize entities that tolerated or concealed wrongdoing. A corporation with a robust compliance program, regular training, and documented enforcement of ethical standards can reduce its culpability score and lower the penalty range significantly. Conversely, a corporation with a history of violations or evidence of management indifference faces a higher multiplier and substantially greater fines. This framework incentivizes corporations to invest in compliance infrastructure and to report violations promptly rather than conceal them.

A corporation should engage federal criminal defense counsel immediately upon learning of a federal investigation, receiving a grand jury subpoena, or discovering conduct that may violate federal law.

Early engagement allows counsel to advise on privilege preservation, document retention protocols, and whether the corporation should conduct an internal investigation and consider voluntary disclosure to prosecutors. In practice, these decisions rarely map neatly onto a single rule; timing, the nature of the conduct, and the corporation's prior compliance record all influence prosecutorial discretion. Counsel can also evaluate whether individual officers should retain separate counsel to manage conflicts of interest, a critical step that prevents later claims of inadequate representation.

When a corporation discovers potential federal criminal conduct, counsel must decide whether to conduct an internal investigation and whether to disclose findings to prosecutors voluntarily. Internal investigations preserve attorney-client privilege if conducted under counsel's direction and are protected from disclosure in litigation. Voluntary disclosure can result in prosecutorial leniency, including deferred prosecution agreements or non-prosecution agreements that allow the corporation to avoid conviction while implementing remedial measures. However, disclosure also creates a record that prosecutors can use and signals cooperation that may require the corporation to waive certain privileges. The decision turns on the severity of the conduct, the likelihood of external discovery, the corporation's compliance history, and the corporation's ability to implement meaningful remediation. Courts in the Southern District of New York and Eastern District of New York have recognized that prompt disclosure coupled with genuine remediation, including personnel changes and compliance investment, can substantially influence charging and sentencing outcomes, though no guarantee of leniency exists.

Beyond criminal penalties, a federal conviction exposes a corporation to debarment from federal contracts, suspension of professional licenses, exclusion from federal healthcare programs, and mandatory disclosure to regulators and customers.

Debarment can last five to ten years or longer and effectively excludes a contractor from federal procurement. License suspension may affect regulated industries such as banking, insurance, pharmaceuticals, and healthcare. Mandatory disclosure obligations require the corporation to report the conviction to securities exchanges, insurance regulators, and federal agencies, triggering shareholder inquiries, investor confidence loss, and potential civil litigation. Employees may also face collateral consequences including professional license suspension or revocation. These cascading effects often exceed the criminal fine itself and justify substantial investment in defense and compliance strategy.

Corporations should document all remedial measures, including compliance program enhancements, personnel discipline, training initiatives, and monitoring systems, to demonstrate to regulators and potential civil litigants that the corporation has addressed root causes. Maintaining detailed records of compliance investments, audit findings, and corrective actions creates a contemporaneous record that can support applications for contract reinstatement, license restoration, or regulatory forgiveness programs. Corporations should also prepare disclosure statements that acknowledge the violation candidly while emphasizing remediation, an approach that often mitigates regulatory and reputational damage more effectively than defensive posturing.